Stay updated with breaking news from 45845p10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT – Get Free Report) has received an average recommendation of “Hold” from the eight research firms that are covering the stock, Marketbeat Ratings reports. Seven equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 1 year target […]
Shares of Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT – Get Free Report) have earned an average recommendation of “Hold” from the eight research firms that are currently covering the stock, Marketbeat reports. Seven analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average twelve-month price objective […]
Intercept Pharmaceuticals (NASDAQ:ICPT – Get Free Report) and Nascent Biotech (OTCMKTS:NBIO – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations and risk. Analyst Recommendations This is a summary of recent […]
StockNews.com assumed coverage on shares of Intercept Pharmaceuticals (NASDAQ:ICPT – Free Report) in a report released on Tuesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other equities research analysts also recently weighed in on ICPT. HC Wainwright downgraded Intercept Pharmaceuticals from a buy rating to a neutral […]
Equities research analysts at StockNews.com started coverage on shares of Intercept Pharmaceuticals (NASDAQ:ICPT – Get Free Report) in a research report issued on Monday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Several other equities analysts have also weighed in on the company. Royal Bank of Canada lifted their price objective on […]